Fordyce Marshall's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Oct 11, 2024
- Accession no.
- 0001415889-24-025024
- Filed
- Oct 11, 2024
- Trade date
- Oct 9, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $597.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fordyce MarshallCIK 0001859453 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2024 | Class A Common Stock | MOption exerciseAcquired | +12,273 | $2.90 | +$35,591.7 | 320,245 | Direct | |
| Oct 9, 2024 | Class A Common Stock | SSaleDisposed | −12,273 | $38.08 | −$467,355.84 | 307,972 | Direct | |
| Oct 9, 2024 | Class A Common Stock | MOption exerciseAcquired | +3,352 | $2.90 | +$9,720.8 | 311,324 | Direct | |
| Oct 9, 2024 | Class A Common Stock | SSaleDisposed | −3,352 | $38.83 | −$130,158.16 | 307,972 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2024 | Class A Common Stock | MOption exerciseDisposed | −15,625 | $0.00 | $0 | 788,587 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.